Redox resetting of Cisplatin resistant ovarian cancer cells by Cisplatin encapsulated Nanostructured Lipid Carriers cisnlc in vivo Pharmacokinetics and Toxicity

dc.contributor.guide	Verma, Anita kamra
dc.coverage.spatial
dc.creator.researcher	Mittal, Disha
dc.date.accessioned	2024-11-08T07:24:06Z
dc.date.available	2024-11-08T07:24:06Z
dc.date.awarded	2021
dc.date.completed	2021
dc.date.registered
dc.description.abstract	Available
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	253 p.
dc.identifier.uri	http://hdl.handle.net/10603/600081
dc.language	English
dc.publisher.institution	Dept. of Zoology
dc.publisher.place	New Delhi
dc.publisher.university	University of Delhi
dc.relation	Bibliography p. 205-253
dc.rights	university
dc.source.university	University
dc.subject.keyword	Life Sciences
dc.subject.keyword	Ovarian cancer, Encapsulated Nanostructured-Lipid Carriers (cisnlc), Cisplatin-resistant, Ovarian cancer cells, Pharmacokinetics, Toxicity
dc.subject.keyword	Plant and Animal Science
dc.subject.keyword	Zoology
dc.title	Redox resetting of Cisplatin resistant ovarian cancer cells by Cisplatin encapsulated Nanostructured Lipid Carriers cisnlc in vivo Pharmacokinetics and Toxicity
dc.title.alternative
dc.type.degree	Ph.D.